Nuvation Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuvation Bio and other ETFs, options, and stocks.About NUVB
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.
CEODavid T. Hung
CEODavid T. Hung
Employees220
Employees220
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2018
Founded2018
Employees220
Employees220
NUVB Key Statistics
Market cap2.86B
Market cap2.86B
Price-Earnings ratio-12.98
Price-Earnings ratio-12.98
Dividend yield—
Dividend yield—
Average volume8.41M
Average volume8.41M
High today$8.56
High today$8.56
Low today$8.11
Low today$8.11
Open price$8.29
Open price$8.29
Volume7.24M
Volume7.24M
52 Week high$8.57
52 Week high$8.57
52 Week low$1.54
52 Week low$1.54
Stock Snapshot
The current Nuvation Bio(NUVB) stock price is $8.40, with a market capitalization of 2.86B. The stock trades at a price-to-earnings (P/E) ratio of -12.98.
On 2025-12-04, Nuvation Bio(NUVB) stock traded between a low of $8.11 and a high of $8.56. Shares are currently priced at $8.40, which is +3.6% above the low and -1.9% below the high.
The Nuvation Bio(NUVB)'s current trading volume is 7.24M, compared to an average daily volume of 8.41M.
In the last year, Nuvation Bio(NUVB) shares hit a 52-week high of $8.57 and a 52-week low of $1.54.
In the last year, Nuvation Bio(NUVB) shares hit a 52-week high of $8.57 and a 52-week low of $1.54.
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own NUVB. This list is generated using Robinhood data, and it’s not a recommendation.